Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Franz-Josef Neumann

Showing results (461-470 of 477) with videos related to

Pageof 48
Sort By:
Eurointervention : Journal of Europcr in Collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology|May 22, 2024
One- versus three-month dual antiplatelet therapy in high bleeding risk patients undergoing percutaneous coronary intervention for non-ST-segment elevation acute coronary syndromesDavide Cao, Pascal Vranckx, Marco Valgimigli, et al.
Eurointervention : Journal of Europcr in Collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology|June 16, 2025
One- versus three-month DAPT after everolimus-eluting stent implantation in diabetic patients at high bleeding risk: results from the XIENCE Short DAPT programmeAngelo Oliva, Dominick J Angiolillo, Marco Valgimigli, et al.
JACC. Cardiovascular Interventions|October 7, 2023
1- or 3-Month DAPT in Patients With HBR With or Without Oral Anticoagulant Therapy After PCIMarco Valgimigli, Alessandro Spirito, Samantha Sartori, et al.
European Heart Journal|January 14, 2016
Histopathological evaluation of thrombus in patients presenting with stent thrombosis. A multicenter European study: a report of the prevention of late stent thrombosis by an interdisciplinary global European effort consortiumJulia Riegger, Robert A Byrne, Michael Joner, et al.
The American Journal of Cardiology|January 7, 2024
1- Versus 3-Month DAPT in Older Patients at a High Bleeding Risk Undergoing PCI: Insights from the XIENCE Short DAPT Global ProgramGennaro Sardella, Alessandro Spirito, Samantha Sartori, et al.
JACC. Cardiovascular Interventions|July 13, 2026
Abbreviated DAPT Regimens Across the Entire Spectrum of Bleeding Risk According to the PRECISE-HBR ScoreDavide Cao, Angelo Oliva, Roxana Mehran, et al.
European Heart Journal|January 25, 2015
ISAR-SAFE: a randomized, double-blind, placebo-controlled trial of 6 vs. 12 months of clopidogrel therapy after drug-eluting stentingStefanie Schulz-Schüpke, Robert A Byrne, Jurrien M Ten Berg, et al.
The New England Journal of Medicine|April 8, 2024
Transcatheter or Surgical Treatment of Aortic-Valve StenosisStefan Blankenberg, Moritz Seiffert, Reinhard Vonthein, et al.
JACC. Cardiovascular Interventions|November 27, 2024
International Consensus Statement on Platelet Function and Genetic Testing in Percutaneous Coronary Intervention: 2024 UpdateDominick J Angiolillo, Mattia Galli, Dimitrios Alexopoulos, et al.
The New England Journal of Medicine|September 3, 2019
Ticagrelor or Prasugrel in Patients with Acute Coronary SyndromesStefanie Schüpke, Franz-Josef Neumann, Maurizio Menichelli, et al.
Pageof 48

Showing results (461-470 of 477) with videos related to

Sort By:
Pageof 48
Eurointervention : Journal of Europcr in Collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology|May 22, 2024
One- versus three-month dual antiplatelet therapy in high bleeding risk patients undergoing percutaneous coronary intervention for non-ST-segment elevation acute coronary syndromesDavide Cao, Pascal Vranckx, Marco Valgimigli, et al.
Eurointervention : Journal of Europcr in Collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology|June 16, 2025
One- versus three-month DAPT after everolimus-eluting stent implantation in diabetic patients at high bleeding risk: results from the XIENCE Short DAPT programmeAngelo Oliva, Dominick J Angiolillo, Marco Valgimigli, et al.
JACC. Cardiovascular Interventions|October 7, 2023
1- or 3-Month DAPT in Patients With HBR With or Without Oral Anticoagulant Therapy After PCIMarco Valgimigli, Alessandro Spirito, Samantha Sartori, et al.
European Heart Journal|January 14, 2016
Histopathological evaluation of thrombus in patients presenting with stent thrombosis. A multicenter European study: a report of the prevention of late stent thrombosis by an interdisciplinary global European effort consortiumJulia Riegger, Robert A Byrne, Michael Joner, et al.
The American Journal of Cardiology|January 7, 2024
1- Versus 3-Month DAPT in Older Patients at a High Bleeding Risk Undergoing PCI: Insights from the XIENCE Short DAPT Global ProgramGennaro Sardella, Alessandro Spirito, Samantha Sartori, et al.
JACC. Cardiovascular Interventions|July 13, 2026
Abbreviated DAPT Regimens Across the Entire Spectrum of Bleeding Risk According to the PRECISE-HBR ScoreDavide Cao, Angelo Oliva, Roxana Mehran, et al.
European Heart Journal|January 25, 2015
ISAR-SAFE: a randomized, double-blind, placebo-controlled trial of 6 vs. 12 months of clopidogrel therapy after drug-eluting stentingStefanie Schulz-Schüpke, Robert A Byrne, Jurrien M Ten Berg, et al.
The New England Journal of Medicine|April 8, 2024
Transcatheter or Surgical Treatment of Aortic-Valve StenosisStefan Blankenberg, Moritz Seiffert, Reinhard Vonthein, et al.
JACC. Cardiovascular Interventions|November 27, 2024
International Consensus Statement on Platelet Function and Genetic Testing in Percutaneous Coronary Intervention: 2024 UpdateDominick J Angiolillo, Mattia Galli, Dimitrios Alexopoulos, et al.
The New England Journal of Medicine|September 3, 2019
Ticagrelor or Prasugrel in Patients with Acute Coronary SyndromesStefanie Schüpke, Franz-Josef Neumann, Maurizio Menichelli, et al.
Pageof 48